Kim CG - Search Results

1

Continuous Separation of Circulating Tumor Cells from Whole Blood Using a Slanted Weir Microfluidic Device.

Yoon Y, Lee J, Ra M, Gwon H, Lee S, Kim MY, Yoo KC, Sul O, Kim CG, Kim WY, Park JG, Lee SJ, Lee YY, Choi HS, Lee SB. Yoon Y, et al. Among authors: kim wy, kim cg, kim my. Cancers (Basel). 2019 Feb 10;11(2):200. doi: 10.3390/cancers11020200. Cancers (Basel). 2019. PMID: 30744156 Free PMC article.

2

A DNA immunoprecipitation assay used in quantitative detection of in vitro DNA-protein complex binding.

Kim MY, Chae JH, Oh CH, Kim CG. Kim MY, et al. Among authors: kim cg. Anal Biochem. 2013 Oct 15;441(2):147-51. doi: 10.1016/j.ab.2013.07.001. Epub 2013 Jul 16. Anal Biochem. 2013. PMID: 23871997

3

Staufen1-mediated mRNA decay induces Requiem mRNA decay through binding of Staufen1 to the Requiem 3'UTR.

Kim MY, Park J, Lee JJ, Ha DH, Kim J, Kim CG, Hwang J, Kim CG. Kim MY, et al. Among authors: kim cg, kim j. Nucleic Acids Res. 2014 Jun;42(11):6999-7011. doi: 10.1093/nar/gku388. Epub 2014 May 5. Nucleic Acids Res. 2014. PMID: 24799437 Free PMC article.

4

Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma.

Kim JS, Son SH, Kim MY, Choi D, Jang IS, Paik SS, Chae JH, Uversky VN, Kim CG. Kim JS, et al. Among authors: kim cg, kim my. Oncotarget. 2017 Apr 11;8(15):24389-24400. doi: 10.18632/oncotarget.15462. Oncotarget. 2017. PMID: 28412749 Free PMC article.

5

Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research.

Kim MY, Choi S, Lee SE, Kim JS, Son SH, Lim YS, Kim BJ, Ryu BY, Uversky VN, Lee YJ, Kim CG. Kim MY, et al. Among authors: kim cg, kim bj, kim js. Cancers (Basel). 2019 Nov 1;11(11):1707. doi: 10.3390/cancers11111707. Cancers (Basel). 2019. PMID: 31683958 Free PMC article.

6

A Feedback Loop Comprising EGF/TGFα Sustains TFCP2-Mediated Breast Cancer Progression.

Zhao Y, Kaushik N, Kang JH, Kaushik NK, Son SH, Uddin N, Kim MJ, Kim CG, Lee SJ. Zhao Y, et al. Among authors: kim cg, kim mj. Cancer Res. 2020 Jun 1;80(11):2217-2229. doi: 10.1158/0008-5472.CAN-19-2908. Epub 2020 Mar 19. Cancer Res. 2020. PMID: 32193292

7

Structural and Functional Insights into CP2c Transcription Factor Complexes.

Son SH, Kim MY, Jo E, Uversky VN, Kim CG. Son SH, et al. Among authors: kim cg, kim my. Int J Mol Sci. 2022 Jun 7;23(12):6369. doi: 10.3390/ijms23126369. Int J Mol Sci. 2022. PMID: 35742810 Free PMC article.

8

SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression.

Son SH, Kim MY, Lim YS, Jin HC, Shin JH, Yi JK, Choi S, Park MA, Chae JH, Kang HC, Lee YJ, Uversky VN, Kim CG. Son SH, et al. Among authors: kim cg, kim my. Sci Adv. 2023 Jan 27;9(4):eadd4969. doi: 10.1126/sciadv.add4969. Epub 2023 Jan 27. Sci Adv. 2023. PMID: 36706181 Free PMC article.

9

Prognostic Implication of YY1 and CP2c Expression in Patients with Primary Breast Cancer.

Cha CD, Son SH, Kim CG, Park H, Chung MS. Cha CD, et al. Among authors: kim cg. Cancers (Basel). 2023 Jul 4;15(13):3495. doi: 10.3390/cancers15133495. Cancers (Basel). 2023. PMID: 37444605 Free PMC article.

10

Improved prediction of protein-protein interactions by a modified strategy using three conventional docking software in combination.

Choi S, Son SH, Kim MY, Na I, Uversky VN, Kim CG. Choi S, et al. Among authors: kim cg, kim my. Int J Biol Macromol. 2023 Dec 1;252:126526. doi: 10.1016/j.ijbiomac.2023.126526. Epub 2023 Aug 24. Int J Biol Macromol. 2023. PMID: 37633550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

795 results

Search Page